Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials

Saved in:
Bibliographic Details
Published in:Diabetes Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867301676050808832
collection WordPress RSS
FRELIP Feed Integration
container_title Diabetes Therapy
description
discipline_display Hematology
discipline_facet Hematology
format Online Article
RSS Article
genre Journal Article
id rss_article:69060
institution FRELIP
journal_source_facet Diabetes Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
Hematology
General
Hematology
sub_discipline_display General
sub_discipline_facet General
subject_display Hematology
General
Hematology
Hematology
General
Hematology
subject_facet Hematology
General
Hematology
title Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
title_auth Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
title_full Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
title_fullStr Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
title_full_unstemmed Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
title_short Correction: Comparative Safety of SGLT2 Versus DPP4 Inhibitors in Patients with Type 2 Diabetes: A Meta‑Analysis of Randomized Controlled Trials
title_sort correction: comparative safety of sglt2 versus dpp4 inhibitors in patients with type 2 diabetes: a meta‑analysis of randomized controlled trials
topic Hematology
General
Hematology
url https://link.springer.com/article/10.1007/s13300-026-01862-8